Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
BRAF
72 Products
72 Products
639 Diseases
36471 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
97
194
291
388
485
582
679
776
873
970
sorafenib
/ Generic mfg.
Stivarga
(regorafenib) / Bayer
Votrient
(pazopanib) / Novartis, BeiGene
Tafinlar
(dabrafenib) / Novartis, BeiGene
Zelboraf
(vemurafenib) / Roche
Braftovi
(encorafenib) / Ono Pharma, Pierre Fabre, Pfizer
Zepsun
(donafenib) / Suzhou Zelgen
avutometinib
(VS-6766) / Verastem
tovorafenib
(DAY101) / Day One Biopharma
RX208
/ Suzhou NeuPharma, Fosun Pharma
naporafenib
(ERAS-254) / Erasca
belvarafenib
(RG6185) / Roche
lifirafenib
(BGB-283) / BeiGene
plixorafenib
(FORE-8394) / Fore Biotherap
ABM-1310
/ ABM Therap
BMS-908662
/ Exelixis
LUT014
/ Lutris Pharma
agerafenib
(RXDX-105) / Roche, Daiichi Sankyo
brimarefenib
(BGB-3245) / MapKure, SpringWorks Therap
tinlorafenib
(PF-07284890) / Pfizer
APL-102
/ Apollomics
PF-07799933
/ Pfizer
RAF265
/ Novartis
iCo-007
/ Ionis
ADXS-503
/ Ayala Pharma
ARQ 736
/ Merck (MSD)
ASN003
/ Asana BioSci
AZ 628
/ AstraZeneca
BAL3833
/ Basilea
BDTX-4933
/ Black Diamond Therap
CFT1946
/ C4 Therap
DCC-3084
/ Deciphera
HyNap-Sora
(sorafenib nanoparticle) / Xspray Pharma
JZP815
/ Jazz
LY3009120
/ Eli Lilly
NST-628
/ Nested Therap
QLH11906
/ Qilu Pharma
RO5212054
/ Daiichi Sankyo
TR128
/ Tarapeutics Science
XP-102
/ Xynomic
exarafenib
(KIN-2787) / Pierre Fabre
